Advancements in Robotic-Assisted Surgery for Prostate Cancer

Abstract

Robotic-assisted surgery has significantly improved the surgical therapy of prostate cancer, the second most frequent malignancy in men. The development and state of robotic-assisted surgery for prostate cancer are examined in this review. Since the introduction of the da Vinci Surgical System in 2000, robotic platforms have developed, improving surgical precision and extending the range of available treatments. The use of robotic devices, including the da Vinci Si and Xi, has enhanced surgical visualisation and crucial structural identification. Alternative platforms, like the Medrobotics Flex® Robotic System, also offer greater versatility and reach.

The robotic-assisted laparoscopic radical prostatectomy (RALP) has emerged as the gold standard in surgical technique. Particularly for erectile function and urine continence, postoperative outcomes have been enhanced by nerve-sparing procedures used in RALP. For particular patient profiles, focal therapy and salvage prostatectomy offer specialised therapeutic choices.

The benefits of robotic surgery, such as fewer complications, better cancer management, and higher patient quality of life, are repeatedly shown by clinical outcomes. Future possibilities are bright for the application of artificial intelligence, tele-mentoring systems, personalised medicine, and virtual reality in surgical planning and training.

Robotic-assisted prostate cancer surgery is still developing, providing better patient care, and the future is looking better thanks to technology developments and teamwork.